Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31.4Revenue (TTM) $M0.5Net Margin (%)-4,371.4Altman Z-Score-13.5
Enterprise Value $M27.7EPS (TTM) $-8.4Operating Margin %-4,024.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-4,371.4Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %-18.5Quick Ratio0.5Cash flow > EarningsY
Price/Sales20.35-y EBITDA Growth Rate %-29.0Current Ratio0.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-63.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-238.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M8.4ROIC % (ttm)-433.6Gross Margin Increase y-yN

Gurus Latest Trades with CLSN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CLSN is held by these investors:



CLSN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fritz Frederick J.Director 2017-07-07Buy13,000$1.8998.94view
Martinez Alberto R JrDirector 2017-02-21Buy2,500$3.2216.77view
Martinez Alberto R JrDirector 2017-02-15Buy3,214$3.0822.08view
Martinez Alberto R JrDirector 2016-11-14Buy714$12.04-68.77view
Martinez Alberto R JrDirector 2016-11-11Buy714$12.74-70.49view
Tardugno Michael HChairman, President and CEO 2016-10-07Buy714$15.96-76.44view
Martinez Alberto R JrDirector 2016-08-16Buy357$17.5-78.51view
Tardugno Michael HChairman, President and CEO 2016-08-16Buy357$17.5-78.51view
Martinez Alberto R JrDirector 2016-06-17Buy357$18.9-80.11view
Tardugno Michael HChairman, President and CEO 2016-06-16Buy536$18.9-80.11view

Press Releases about CLSN :

Quarterly/Annual Reports about CLSN:

News about CLSN:

Articles On GuruFocus.com
Celsion Provides Summary of Research and Development Day Held on October 12, 2017 Oct 18 2017 
Celsion Provides Summary of Research and Development Day Held on Thursday, October 12, 2017 Oct 17 2017 
Celsion Announces Publication of the HEAT Study Manuscript in the High Impact Journal, Clinical Canc Oct 16 2017 
Celsion to Host Research and Development (R&D) Day on Thursday, October 12, 2017 Oct 12 2017 
Celsion Corporation Announces Gross Proceeds of $15.6 Million from the Exercise of Existing Common S Oct 04 2017 
Celsion to Host Research and Development Update October 12, 2017 Oct 04 2017 
Celsion Announces Final Clinical and Translational Research Data from its OVATION Study at the AACR Oct 03 2017 
Celsion Provides Update on ThermoDox® in the Phase III OPTIMA Study of Primary Liver Cancer Sep 27 2017 
Celsion Announces Presentation of OVATION Study Findings at the Upcoming AACR Special Conference Aug 24 2017 
Celsion Corporation to Hold Second Quarter 2017 Financial Results Conference Call on Tuesday, August Aug 08 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK